SK
Suvendu Kapilchandra Ghosh
About Suvendu Kapilchandra Ghosh
Suvendu Kapilchandra Ghosh has 31 years in corporate governance. Holds Director role. Currently with 1 company, including Nexfa Private Limited. Formerly with 3 companies, such as Excellar Healthcare Private Limited and Excell Formulations Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Nexfa Private Limited
U51909WB2022PTC251080
|
Director | 01 Apr 2023 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Excellar Healthcare Private Limited
U24239MH2007PTC168852
|
Director | 24 Jan 2008 | 2007 | Active |
Excell Formulations Private Limited
U24230MH1995PTC087403
|
Director | 19 Apr 1995 | 1995 | Active |
Rohika Pharmaceuticals Private Limited
U74999MH2016PTC272133
|
Director | 15 Jan 2016 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suvendu Kapilchandra Ghosh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suvendu Kapilchandra Ghosh
Suvendu Kapilchandra Ghosh has 31 years in corporate governance. Holds Director role. Currently with 1 company, including Nexfa Private Limited. Formerly with 3 companies, such as Excellar Healthcare Private Limited and Excell Formulations Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Suvendu Kapilchandra Ghosh is associated with 1 company as Director.
Suvendu Kapilchandra Ghosh has expertise in General Business, Healthcare.
Suvendu Kapilchandra Ghosh has 31 years in corporate governance.